Basser in the News

Basser Executive Director Susan Domchek, MD, was featured in Good Morning America, The Philadelphia Inquirer, Philadelphia Magazine, Chicago Tribune, and Ebony, where she discussed male breast cancer and BRCA mutations related to the announcement that Mathew Knowles has BRCA-related breast cancer. 

Tune in this Friday to the Dr. Oz Show, where Dr. Domchek and Mathew Knowles will discuss his recent diagnosis.

Throughout October, Penn Medicine physicians, patients, and advocates will contribute to breast cancer awareness month with a series of op-eds each week for The Philadelphia Inquirer. In the first piece, Dr. Domchek marked 25 years since BRCA1 was first cloned, explored the advances in the field since that milestone, and looked to the future for areas of growth.
All month on Twitter, we're teaming up with Penn Medicine to explore the history of BRCA-research, highlighting the milestones, experts, patients, and advocates whose collaboration and innovation is saving the lives of people with cancer-causing BRCA1 and BRCA2 genetic mutations. Follow @basserBRCA and @pennmedbench on Twitter for more.

BFOR Study

The BRCA Founder Research study (BFOR) continues to facilitate access to genetic testing for women and men age 25 or older with at least one grandparent of Ashkenazi (Eastern European) ancestry. 
BFOR offers no-cost genetic testing for BRCA mutations that occur in 1 in 40 individuals of Ashkenazi Jewish ancestry, which is 10 times more likely than the general population. Individuals who carry a BRCA mutation have an increased risk of developing breast, ovarian, prostate and pancreatic cancers. The study is available to those interested until December 31, 2019. Register and learn more.

Hereditary Cancer Risk and Prevention

  • Basser Young Leadership Council member Katrina Wells writes about her experience managing ovarian cancer risk and preventative surgery for the Basser blog.

  • As the first in a series of articles from genetic counselors at the Basser Center, Jackie Powers, MS, LCGC, writes about how to approach preventative surgery for the Basser blog.

  • Basser Center clinician Kara N. Maxwell, MD, PhD, discusses with Survivor Net the new guidelines suggesting women at high risk for breast cancer can take tamoxifen, raloxifene, and aromatase to lower their risk.

  • Basser Young Leadership Council co-chair Erika Stallings writes about why she chose to undergo a preventative mastectomy for Lifetime.
This Hispanic Heritage Month, learn about your family health history and your risk for hereditary cancer. Check out our educational resources in Spanish at basser.org/latinxbrca.
The Basser Center is proud to host, sponsor, and participate in events throughout the country.
October 28, 2019
UJA-Federation of New York's The BRCA Gene: Let's Talk About It panel with Basser Executive Director Susan Domchek, MD (New York, NY)
November 5, 2019
November 18, 2019
Basser Jean Bash (New York, NY)
Basser Center
Facebook Twitter Instagram
basser.org | 215.662.2748
Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.
This email was sent to samantha.deighan@uphs.upenn.edu.
Continue receiving our emails, add us to your address book.